ONO Pharmaceutical Co (4528N) Q2 2020 Earnings Report
MX:4528N Q2 2020 EPS Results
- Actual EPS
- MXN 4.38
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- MXN 3.90
MX:4528N Q2 2020 Revenue Results
- Actual Revenue
- MXN 9.01B
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- -31.39%
Earnings Announcement Details
- Quarter
- Q2 2020
- Date
- 10/29/2020
- Time
- TBA
- Conference Call
- Thursday, October 29, 2020
MX:4528N Upcoming Earnings
ONO Pharmaceutical Co's next earnings date is estimated for February 1, 2027, based on past reporting schedules.
Q2 2020 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2020 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2020 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:4528N Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 01, 2027 | 2026 (Q3) | 5.58- | 7.32 | ― | ― |
| Oct 29, 2026 | 2026 (Q2) | 5.195.27 | 5.69 | -7.36% (-0.42) | |
| Jul 31, 2026 | 2026 (Q1) | 4.146.13 | 4.49 | 36.63% (+1.64) | |
| May 08, 2026 | 2025 (Q4) | 0.980.21 | -1.66 | 112.48% (+1.87) | |
| Feb 02, 2026 | 2025 (Q3) | 5.407.32 | 3.8 | 92.96% (+3.53) | |
| Oct 30, 2025 | 2025 (Q2) | 4.855.69 | 4.28 | 33.00% (+1.41) | |
| Aug 01, 2025 | 2025 (Q1) | 5.904.49 | 6.29 | -28.74% (-1.81) | |
| May 08, 2025 | 2024 (Q4) | 1.65-1.66 | 5.65 | -129.41% (-7.31) | |
| Feb 03, 2025 | 2024 (Q3) | 4.993.80 | 9.03 | -57.98% (-5.24) | |
| Oct 31, 2024 | 2024 (Q2) | 6.034.28 | 10.51 | -59.32% (-6.24) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
